Cardiol Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
TEJARA CAPITAL LTD | 05/13/2025 | 3.19 M | $3.10 M | 2.55% | 4.57% |
ADVISORSHARES INVESTMENTS LLC | 05/13/2025 | 982.49 K | $911.36 K | 11.33% | 1.41% |
MMCAP INTERNATIONAL INC. SPC | 05/12/2025 | 782.63 K | $758.99 K | -1.63% | 1.12% |
UBS GROUP AG | 05/13/2025 | 497.86 K | $482.92 K | 112.02% | 0.71% |
PVG ASSET MANAGEMENT CORP | 06/04/2025 | 437.36 K | $424.15 K | -10.25% | 0.63% |
LION STREET ADVISORS, LLC | 04/18/2025 | 333.73 K | $317.70 K | 8.47% | 0.48% |
ENVESTNET ASSET MANAGEMENT INC | 04/29/2025 | 329.15 K | $314.57 K | 6.29% | 0.47% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/22/2025 | 321.29 K | $310.00 K | -2.79% | 0.46% |
ATRIA INVESTMENTS, INC | 05/06/2025 | 139.05 K | $134.85 K | 2.33% | 0.20% |
MGO ONE SEVEN LLC | 05/08/2025 | 100.00 K | $96.98 K | 0.00% | 0.14% |
KNOLL CAPITAL MANAGEMENT, LLC | 05/15/2025 | 100.00 K | $96.90 K | 0.00% | 0.14% |
CETERA INVESTMENT ADVISERS | 05/06/2025 | 67.56 K | $64.84 K | 55.15% | 0.10% |
MORGAN STANLEY | 05/15/2025 | 59.61 K | $57.81 K | -70.86% | 0.09% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 55.00 K | $53.35 K | 100.00% | 0.08% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 52.44 K | $50.85 K | 0.00% | 0.08% |
BANK OF MONTREAL /CAN/ | 05/13/2025 | 50.08 K | $47.68 K | 0.16% | 0.07% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 39.20 K | $38.02 K | 9.19% | 0.06% |
MARBLE HARBOR INVESTMENT COUNSEL, LLC | 05/09/2025 | 36.90 K | $35.79 K | 0.00% | 0.05% |
CITADEL ADVISORS LLC | 05/15/2025 | 25.90 K | $25.12 K | 428.57% | 0.04% |
JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 21.06 K | $20.22 K | 6.11% | 0.03% |
VIRTU FINANCIAL LLC | 05/12/2025 | 16.04 K | $16.00 K | -66.61% | 0.02% |
WEALTHSPIRE ADVISORS, LLC | 05/09/2025 | 15.15 K | $14.69 K | 0.00% | 0.02% |
ROYAL BANK OF CANADA | 05/15/2025 | 12.81 K | $12.00 K | -48.33% | 0.02% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 11.20 K | $10.85 K | -2.61% | 0.02% |
INDEPENDENT ADVISOR ALLIANCE | 05/12/2025 | 10.00 K | $9.70 K | 100.00% | 0.01% |
NATIONAL BANK OF CANADA /FI/ | 05/12/2025 | 8.56 K | $8.15 K | 45.51% | 0.01% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 8.45 K | $8.19 K | 59.15% | 0.01% |
TD WATERHOUSE CANADA INC. | 05/09/2025 | 6.90 K | $6.43 K | 0.00% | 0.01% |
PISCATAQUA SAVINGS BANK | 04/11/2025 | 5.00 K | $10.25 K | 0.00% | 0.01% |
VALLEY NATIONAL ADVISERS INC | 04/25/2025 | 5.00 K | $4.00 K | 0.00% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 4.29 K | $4.10 K | 14.56% | 0.01% |
HARTFORD FINANCIAL MANAGEMENT INC. | 04/21/2025 | 4.00 K | $3.88 K | 0.00% | 0.01% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.70 K | $1.65 K | -55.26% | 0.00% |
SOUTHSTATE CORP | 05/12/2025 | 1.00 K | $970 | 0.00% | 0.00% |
05/15/2025 | 556 | $490 | 100.00% | 0.00% | |
05/02/2025 | 475 | $461 | 72.73% | 0.00% | |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 118 | $114 | 100.00% | 0.00% |
STONE HOUSE INVESTMENT MANAGEMENT, LLC | 05/13/2025 | 50 | $48 | 100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 25 | $24 | -98.75% | 0.00% |
TORONTO DOMINION BANK | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
MAI CAPITAL MANAGEMENT | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
MARSHALL WACE, LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
LPL FINANCIAL LLC | 05/07/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 04/16/2025 | 0 | $0 | -100.00% | 0.00% |
NEW WAVE WEALTH ADVISORS LLC | 04/25/2025 | 0 | $0 | -100.00% | 0.00% |
04/24/2025 | 0 | $0 | -100.00% | 0.00% |
Cardiol Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 45 institutional investors and hedge funds held shares of Cardiol Therapeutics Inc.. The most heavily invested institutionals were:
Tejara Capital Ltd: 3.19 M
AdvisorShares Investments LLC: 982,488
MMCAP International Inc. SPC: 782,625
UBS Group AG: 497,857
PVG ASSET MANAGEMENT CORP: 437,362
Lion Street Advisors, LLC: 333,725
11.04% of Cardiol Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.80 M shares in the last 24 months. This purchase volume represents approximately $12.02 M in transactions.